Cardiometabolic index predicts cardiovascular events in aging population: a machine learning-based risk prediction

Yuanxi Luo1,2, Zhiyang Yin3, Xin Li1,2

  • 1Department of Cardiac Surgery, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Graduate School of Peking Union Medical College, Beijing, China.

PubMed

Insights

The Cardiometabolic Index (CMI) predicts cardiovascular disease (CVD) events in older adults, with hypertension and insulin resistance as key factors. A new nomogram using CMI aids in early risk assessment for stroke prevention.

Area of Science:

  • Cardiology
  • Metabolic Health
  • Geriatrics

Background:

  • Cardiovascular disease (CVD) remains a leading cause of mortality in aging populations.
  • The Cardiometabolic Index (CMI) is an emerging marker for adipose tissue distribution and metabolic dysfunction.
  • The prognostic value of CMI for CVD events requires further elucidation.

Purpose of the Study:

  • To evaluate the predictive capability of CMI for cardiovascular outcomes.
  • To explore the mechanistic pathways linking CMI to CVD.
  • To develop a comprehensive risk prediction framework for CVD events.

Main Methods:

  • Analysis of 7,822 individuals from a national health and retirement longitudinal cohort.
  • Stratification by CMI quartiles and assessment of CVD incidence rates.
  • Application of Cox regression and ensemble machine learning (Random Forest, XGBoost) for risk prediction and nomogram development.

Main Results:

  • A positive association was observed between increasing CMI quartiles and CVD incidence.
  • Hypertension and elevated HbA1c were identified as potential mediators in the CMI-CVD relationship.
  • A validated nomogram incorporating CMI demonstrated strong predictive accuracy for stroke events.

Conclusions:

  • CMI is a significant predictor of cardiovascular events in the elderly population.
  • Hypertension and insulin resistance pathways partially mediate the association between CMI and CVD.
  • The developed nomogram facilitates preclinical risk stratification for timely preventive interventions.
Abstract